Bacteremia From Periodontal Treatment to Elucidate the Underpinnings of Sepsis
Launched by MALMÖ UNIVERSITY · Sep 22, 2020
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how treating gum disease (periodontal disease) may affect bacteria levels in the blood and their connection to serious conditions like sepsis (a life-threatening response to infection) and heart disease. Researchers want to find out if certain biological markers can help detect current or past bacterial infections that might arise from dental treatments. They are especially interested in understanding the long-term effects of treating gum disease compared to not treating it and how these bacteria might relate to heart health.
To participate in the study, individuals must have periodontal disease but cannot have used antibiotics recently. As of March 2024, 78 people have already joined the trial, which is still looking for more participants. Those involved can expect to undergo assessments that will help researchers learn more about the relationship between gum health, bacteria in the blood, and heart disease. The findings from this trial could lead to quicker treatment for sepsis and improved methods for preventing infections during dental visits.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Periodontal disease
- Exclusion Criteria:
- • Recently used antibiotics.
About Malmö University
Malmö University is a leading academic institution located in Sweden, renowned for its commitment to innovative research and high-quality education. With a strong emphasis on interdisciplinary collaboration and community engagement, the university actively contributes to advancements in various fields, including health sciences. As a clinical trial sponsor, Malmö University leverages its extensive expertise and resources to facilitate cutting-edge research initiatives aimed at improving patient outcomes and addressing critical healthcare challenges. The institution is dedicated to ethical research practices and the dissemination of knowledge, fostering a robust environment for scientific discovery and clinical advancement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lund, , Sweden
Patients applied
Trial Officials
Daniel Jonsson, DDS PhD
Principal Investigator
Malmo University, Lund University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials